Popular Articles From: UPDATE: Family Dollar's shares still cushioned by merger hope to UPDATE: What Olive Garden's 'never ending pasta pass' distracts patrons from realizing


2014/10/10
By Andria Cheng, MarketWatch NEW YORK (MarketWatch)--Family Dollar Stores Inc. delivered another disappointing result late Thursday and said this quarter will be its most challenging in the new fiscal year.
Sign-up for UPDATE: Family Dollar's shares still cushioned by merger hope investment picks
2014/11/7
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Sears Holdings Corp.'s announcement that it is exploring the notion of turning up to 300 stores over to a REIT sent its shares soaring as much as 48% -- the stock's biggest daily gain in at least 10 years.
Sign-up for UPDATE: Creating REIT won't help Sears build bridge to profitability: analysts investment picks
2014/10/10
By Andria Cheng, MarketWatch NEW YORK (MarketWatch)--Family Dollar Stores Inc. delivered another disappointing result late Thursday and said this quarter will be its most challenging in the new fiscal year.
Sign-up for Family Dollar's shares still cushioned by merger hope investment picks
2014/9/4
By Anora Mahmudova, Carla Mozee and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- European Central Bank's surprise interest-rate cuts and new bond-buying program sent the S&P 500 and Dow Jones Industrial Average to intraday record highs.
Sign-up for UPDATE: S&P 500, Dow hit intraday record highs investment picks
2014/9/16
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- The U .S. equity market opened lower on Tuesday, as investors remained risk averse and avoided tech and small-cap stocks.
Sign-up for UPDATE: U.S. stocks weaken ahead of FOMC meeting investment picks
2014/9/8
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks moved lower on Monday as investors turned cautious after five straight weeks of gains that sent the main benchmark to record highs.
Sign-up for UPDATE: U.S. stocks fall; S&P 500 dips below 2,000 investment picks
Accenture (NYSE:ACN) has been selected by American International Group, Inc. (AIG), a leading international insurance organization serving customers in more than 130 countries, to transform its software platform.
Sign-up for AIG Selects Life & Annuity Software from Accenture to Reduce Costs and Prepare for Future Business Growth investment picks
Accenture (NYSE:ACN) was positioned in the “Leaders” quadrant in Gartner’s recently published “Magic Quadrant for North American Life Insurance Policy Administration Systems 1 ” evaluated for its Accenture Life Insurance Platform .
Sign-up for Accenture Improves Position in “Leaders” Quadrant of Gartner’s Magic Quadrant for North American Life Insurance Policy Administration Systems investment picks
OvaScience℠ (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Rodman & Renshaw 16 th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., on Wednesday, September 10, 2014 at 10:25 am ET at the New York Palace Hotel.
Sign-up for OvaScience to Present at the Rodman & Renshaw/H.C. Wainwright Annual Global Investment Conference investment picks
IMS Health (NYSE:IMS) announced today that Ron Bruehlman, senior vice president and chief financial officer, will participate in a “fireside chat” at the Stifel Healthcare Conference in New York City on Wednesday, November 19, 2014 at 11:30 a.m. Eastern Time.
Sign-up for IMS Health to Participate in Stifel Healthcare Conference on November 19, 2014 investment picks
2014/9/10
By Atsuko Fukase and Eric Pfanner The biggest temporary staffing company in Japan, Recruit Holdings Co., said it plans a $1.8 billion initial public stock offering next month, in a bid to finance its ambition of transforming itself into the largest player in the industry worldwide.
Sign-up for Japan's Recruit Holdings plans $1.8 billion IPO next month investment picks
2014/10/29
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- Stock futures largely stuck to the flat line ahead of a decision from the Federal Open Market Committee, though technology stocks look set to see pressure as Facebook Inc. shares fell after results.
Sign-up for UPDATE: U.S. stocks: Futures flat as Fed looms; Facebook under pressure investment picks
2014/10/30
By Barbara Kollmeyer, MarketWatch NEW YORK MarketWatch) -- The Dow Jones Industrial Average vaulted higher on Thursday trading, dragging the other major U.S. benchmarks higher as well.
Sign-up for MARKET SNAPSHOT: Dow Rings Up Eighth Triple-digit Gain In October investment picks
2014/10/17
By Barbara Kollmeyer, MarketWatch MADRID (MarektWatch) -- The new iPhone hitting the shelves in China on Friday could have been a downright dull affair on Friday had it not been for one fast-thinking wireless operator that figured out how to get that big iPhone 6 Plus into customer's pockets.
Sign-up for How to make the iPhone 6 Plus fit in your pants -- the Shanghai way investment picks
2014/10/28
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- Less money, fewer problems.
Sign-up for Bill Gross likely took a big pay cut to join Janus investment picks
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- The investor money that followed Bill Gross out the door at Pimco is landing on the steps of other large asset managers.
Sign-up for UPDATE: These funds are benefiting from Bill Gross's Pimco exit investment picks
By Benjamin Pimentel, MarketWatch SAN FRANCISCO (MarketWatch) -- Three years after Steve Jobs's death, his handpicked successor, Apple Chief Executive Tim Cook, is leading a major product offensive that could set the tech giant's course in the post-Jobs era.
Sign-up for Apple's Cook set to lead post-Jobs era offensive investment picks
WHITEHOUSE STATION, N.J. , Sept.
Sign-up for Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in PD-L1 positive, advanced urothelial cancer (also known as bladder cancer). The early findings presented showed a confirmed overall response rate of 24 percent with KEYTRUDA as monotherapy, as measured by RECIST v1.1, central review (n= 7/29: 95% CI, 10.3-43.5) including a complete response rate of 10 percent (3/29). At the time of analysis, response durations ranged from 16+ to 40+ weeks with six of the seven responders continuing on therapy.
Sign-up for Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014 investment picks
2014/9/2
By Bradley Hope The day after Jeffrey Sprecher, the chairman and chief executive of Atlanta's Intercontinental Exchange Inc., took control of the New York Stock Exchange, he sent trusted lieutenant Thomas Farley to size up the 222-year-old icon of capitalism.
Sign-up for Can the New York Stock Exchange be saved? investment picks
TICKER SYMBOL (NYSE: UFS) (TSX: UFS) Widest range of FSC ® certified, sustainable North American papers on the market MONTREAL , Sept.
Sign-up for Domtar celebrates sale of five million tons of Forest Stewardship Council® certified paper investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Tesco PLC and HSBC PLC dropped in London trade on Monday after major shareholders cut their stakes in each company.
Sign-up for UPDATE: Tesco, HSBC shares drop in London trading investment picks
2014/9/16
By Catey Hill, MarketWatch You may have to wait until October to get your new iPhone 6 or iPhone 6 Plus.
Sign-up for UPDATE: Will iPhone 6 shipping delays leave you phone-less? investment picks
2014/9/5
By Catey Hill, MarketWatch Are you ready to sport a man purse?
Sign-up for UPDATE: 5 ways the iPhone 6 could alter fashion investment picks
2014/10/11
By Catey Hill, MarketWatch Many a shopper has walked out of warehouse clubs like Costco (COST) and Sam's Club (WMT) with a receipt containing at least a few extra zeros.
Sign-up for UPDATE: 5 things NOT to buy at Costco and Sam's Club investment picks
2014/10/8
By Catey Hill, MarketWatch Many a shopper has walked out of warehouse clubs like Costco (COST) and Sam's Club (WMT) with a receipt containing at least a few extra zeros.
Sign-up for UPDATE: 5 things NOT to buy at Costco and Sam's Club investment picks
2014/9/27
By Charles Passy, MarketWatch I'll say this much for Olive Garden: It knows something about America's insatiable appetite.
Sign-up for UPDATE: What Olive Garden's 'never ending pasta pass' distracts patrons from realizing investment picks
2014/11/7
By Charles Passy, MarketWatch I'll say this much for Olive Garden: It knows something about America's insatiable appetite.
Sign-up for UPDATE: What Olive Garden's 'never ending pasta pass' distracts patrons from realizing investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: UPDATE: Family Dollar's shares still cushioned by merger hope to UPDATE: What Olive Garden's 'never ending pasta pass' distracts patrons from realizing
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent